Recent Posts

• RoZetta’s global commercialisation success story continues with sale of Lorica Health
• When High-frequency Traders Stay Isolated For COVID-19
• The “end” of roaring 2010’s yield-enhancing strategies – a Buy-Side perspective
• Measuring the influence of COVID-19 on the Australian property sector
• How RoZetta Institute research limits the impact of flash crashes